Daré Bioscience, Inc. (NASDAQ:DARE) Shares Acquired by AMH Equity Ltd

AMH Equity Ltd increased its position in shares of Daré Bioscience, Inc. (NASDAQ:DARE) by 50.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 150,000 shares of the biotechnology company’s stock after purchasing an additional 50,000 shares during the period. AMH Equity Ltd owned 1.72% of Daré Bioscience worth $468,000 at the end of the most recent quarter.

Daré Bioscience Trading Up 1.6 %

Shares of NASDAQ:DARE opened at $3.18 on Thursday. The firm has a 50 day simple moving average of $3.19 and a 200-day simple moving average of $3.38. Daré Bioscience, Inc. has a twelve month low of $2.67 and a twelve month high of $7.56. The company has a market capitalization of $27.67 million, a PE ratio of -5.38 and a beta of 1.32.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and issued a $12.00 price target on shares of Daré Bioscience in a research note on Tuesday, December 17th.

Daré Bioscience Company Profile

Daré Bioscience, Inc, a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older.